echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Plant Extracts News > Anhui issued 50 drug quality risk warning varieties in 2019, which are under key supervision

    Anhui issued 50 drug quality risk warning varieties in 2019, which are under key supervision

    • Last Update: 2019-02-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On February 14, Anhui drug regulatory bureau issued the drug quality risk warning varieties in 2019, and 50 problematic drugs such as Pudilan Xiaoyan tablet, netilmicin sulfate injection, osteopeptide injection and Angelica dahurica will be under key supervision In order to strengthen risk control, realize early attention, early warning and early detection of quality risk varieties, the provincial drug administration, in combination with the characteristics of varieties, national assessment sampling, provincial and municipal supervision and inspection, lists 50 varieties prone to quality problems into the drug quality risk warning products in 2019 The list of drug quality risk warning varieties in 2019 includes 14 traditional Chinese medicine preparations such as Xiaochaihu granules, 12 chemical preparations such as vitamin B complex tablets, 7 biochemical preparations such as human immunoglobulin preparations, 17 traditional Chinese medicine and decoction pieces such as areca Among them, traditional Chinese medicine preparations include Xiaochaihu granules, snake bile containing preparations, Huoxiang Qushu soft capsule, Bushen Jianshen tablets, Lidan tablets, anti bone hyperplasia series, Pudilan Xiaoyan tablets, lifeI tablets, safflower containing preparations, runing tablets, Danshen drops, Cinobufacin injection, Antheraea repelling injection and Yitongshu injection Chemical preparations include compound vitamin B tablets, netilmicin sulfate injection, benproperine phosphate tablets, fluoxetine acetate ice cream, Chlortetracycline Hydrochloride Eye Cream, Yanlixiao capsule, Telmisartan Tablets, azithromycin granules, acyclovir cream, tenofovir fumarate dipivoxil tablets, entecavir dispersible tablets, lamivudine tenofovir tablets Biochemical preparations include Human Immunoglobulin preparation, Human Albumin preparation, Hemocoagulase Injection, Deproteinized Calf Blood Extract Eye Gel, bone peptide injection, Oxytocin Injection, cytochrome C injection Herbs and slices include areca, dragon's blood, peppermint, Rehmannia glutinosa, psoralen, angelica, gallus, Angelica dahurica, Radix et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Radix, Radix et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma Angelicae dahuricae, Radix Angelicae dahuricae, Radix Angelicae dahuricae, Radix et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma Angelicae dahuricae, Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma et Rhizoma Angelicae dahur
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.